1. Generics Bulletin
  2. >>Policy & Regulation
  3. >>Regulation

Industry Urges Action In Bulgaria

Country Should Eliminate Clawback Tax And Drive Up Volumes

 
• By Dave Wallace

Bulgaria should remove clawback taxes for generics and biosimilars, avoid external reference-pricing mechanisms, adopt measures to drive up generic prescribing and adopt a “dynamic” biosimilars policy to encourage uptake, European off-patent industry association Medicines for Europe has urged. The industry body has also called on the new European Commission to offer the country its support in these areas.

Bulgaria_Map
Medicines for Europe has called for a series of actions in Bulgaria • Source: Shutterstock

Action must be taken in Bulgaria to bolster the country’s generics and biosimilars market, according to European off-patent industry association Medicines for Europe.

In particular, the association has called for Bulgaria to remove clawback taxes for generics and biosimilars; avoid external reference-pricing mechanisms; adopt measures to drive up “rational” generic

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation